
|Articles|March 1, 1999
The American Journal of Managed Care
- March 1999
- Volume 5
- Issue 3
Dissecting Cost-Effectiveness Analysis for Preventive Interventions: A Guide for Decision Makers
Advertisement
Articles in this issue
over 26 years ago
Economic Impact of Delaying or Preventing AIDS in Persons with HIVover 26 years ago
Erectile Dysfunction: The Primary Care Practitioner's Viewover 26 years ago
Drug-Nutrient InteractionsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
5














































